Stable non-dihydrate azithromycin oral suspensions

   
   

This invention relates to a powder for oral suspension, and an oral suspension made therefrom, which comprises a n-propanol solvate of non-dihydrate azithromycin and an azithromycin conversion stabilizing excipient, wherein said excipient reduces the conversion of the form of azithromycin, when placed in suspension, to another form of azithromycin. This invention also relates to an oral suspension which comprises a n-propanol solvate of non-dihydrate azithromycin and an aqueous vehicle.

Esta invenção relaciona-se a um pó para a suspensão oral, e a uma suspensão oral feita therefrom, que compreenda um solvate do n-n-propanol do azithromycin do non-non-dihydrate e de um excipient se estabilizando da conversão do azithromycin, wherein o excipient dito reduz a conversão do formulário do azithromycin, quando colocado na suspensão, a um outro formulário do azithromycin. Esta invenção relaciona-se também a uma suspensão oral que compreenda um solvate do n-n-propanol do azithromycin do non-non-dihydrate e de um veículo aqueous.

 
Web www.patentalert.com

< Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy

< Recombinant parainfluenza virus expression system and vaccines

> Multivalent MHC class II--peptide chimeras

> Method for producing a coenzyme Q10/.gamma.-cyclodextrin complex

~ 00165